Cream does move to the top. Caught my ear as well...

Otto Yang..."And so I would point out that, at least at our Center that has become a niche for Leronlimab because we are a very large transplant center, one of the biggest in the country, and the transplant surgeons are tremendously protective of their patients for good reason in terms of experimental treatments. But with Leronlimab they're fully comfortable, I must admit, because they have seen that it has had no issues with enhancing their immunosuppression and causing infection."